IL4 and type 1 diabetes mellitus: Since this is the first study using genetically modified L. lactis in the STZ-induced T1D model, these results were important and led to the investigation of the effects of the combined administration of L. lactis MG1363 FnBPA+ strains carrying the IL-4 and IL-10-coding plasmids in the NOD mouse model.